News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, October 1, 2018

Beginning Grantwriting Workshop will be held on Friday, November 9, 9:00 am to 12:00 pm

at 840 Research Parkway, Suite 400, in Oklahoma City. Research Park is off Lincoln Blvd. between

4th and 8th street. The content of Beginning Grantwriting is how to plan a grant proposal, how to

gather information for the plan, and how to schedule your writing time. Tips for good writing will be

provided.

Grant Resources Searching Workshop will be held on the same day, Friday, November 9,

1:00 pm to 3:00 pm, in the same room. Grant Resources Searching will cover how to search for

Foundation Grants and how to search for Federal Grants. Bring your laptop and search in class.

Lunch will be on your own. There are 2 restaurants in an adjacent building. There is no fee, but

you must register. Send an email with your name, your college or university affiliation, and position

to lmason@osrhe.edu.

 

 

ORAU-Directed Research and Development (ODRD) Program

The FY 2019 competition for collaborative awards of up to $75,000 to be shared between the

university and ORAU researchers is now open. We anticipate and expect that these seed funds

will position the collaborative teams to be more competitive for new, external funding opportunities.

The deadline for joint ORAU/university proposals is March 25, 2019 and potential university partners

are encouraged to submit concepts for discussion with ORAU partners as soon as possible. 

https://www.orau.org/university-partnerships/member-grant-programs/odrd.html

 

 

ANNOUNCING NEW PHF SEED GRANT PROGRAM -- PHF 3D BIO-PRINTING SEED

GRANT PROGRAM

Proposal Deadline: Friday, October 26, 2018

The Presbyterian Health Foundation (PHF) Three-Dimensional (3D) Bio-Printing Seed Grant Program

will support projects that utilize new and innovative 3D bio-printing technologies aimed at revolutionizing

medical practice, drug discovery processes, and the study of the fundamental mechanisms of disease. 

The overall goal of this program is to provide a one-year grant for OUHSC investigators to initiate

research programs utilizing the new 3D BioAssemblyBot® (Advanced Solutions) bio-printer,

website: https://lifesciences.solutions/bioassemblybot/.  Additional information about basic supplies

can be on found on https://lifesciences.solutions/categories/.

Applicants may request support of up to $40,000 for one year. Guidelines and Application Form is

attached or go to:

https://research.ouhsc.edu/News/TabId/9629/ArtMID/25795/ArticleID/8068/New-PHF-Opportunity--3D-Bio-Printing-Seed-Grant.aspx.

https://research.ouhsc.edu/Portals/1329/Assets/Documents/PHF 3D Bio-printing Seed Grant-Guidelines - Final - 2018.docx?ver=2018-10-01-072221-013

 

The Center for Indigenous Health Research and Action (CIHRA) and the OU-Tulsa

Office of Research and Scholarly Development

present the 2ND ANNUAL OU-TULSA COMMUNITY RESEARCH SYMPOSIUM

"Trauma-Informed Community Building for Health"

This symposium focuses on the relationship between trauma, health and well-being. Both local and

national presenters will be featured including Julie Miller-Cribbs, PhD, Director & Oklahoma Medicaid

Endowed Professor in Mental Health at the University of Oklahoma Anne & Henry Zarrow School of

Social Work, Emma Elliot-Groves, PhD, Assistant Professor of Medicine, Washington State University,

Schelli Slaughter, DrPH, Director of Public Health, Thurston County Washington, and others.

Presenters will discuss how communities can build hope-informed systems to improve health.

The symposium is free, open to the public, and provides breakfast and lunch.

Continuing Education credits available.

WHERE & WHEN:

Monday, Oct. 22  //  8am – 4pm

Schusterman Learning Center  //  Perkins Auditorium // OU-Tulsa

RSVP: https://calendar.ou.edu/tulsa-research/view/event/event_id/69118

For additional information email: ordsa@ouhsc.edu or danielle-fousel@ouhsc.edu

For CIHRA-sponsored events or information email: Charlotte-V-Love@ouhsc.edu

https://research.ouhsc.edu/Portals/1329/Assets/Documents/Trauma Invite.pdf?ver=2018-10-01-072212-030

 

Grants and Contracts Newsletter for September 2018 is attached.

https://research.ouhsc.edu/Portals/1329/Assets/Documents/GCA News September 2018.pdf?ver=2018-10-01-074100-207

 

AAMC - FOCI Community,

You have likely been following discussions at your institution and in the national press about disclosure

and transparency issues in light of the recent resignation of Memorial Sloan Kettering Cancer Center’s

Chief Medical Officer, Dr. José Baselga, following a New York Times article about his failure to disclose

industry ties in a large number of publications. The attached memorandum discusses some of the

background, related AAMC activities, and some immediate steps you can take to communicate with

your faculty about this situation and our shared obligation to facilitate the disclosure of timely, accurate,

and complete information about academic medicine’s relationships with industry.

This is the beginning of a much larger conversation in which all of you are engaged at your institutions

and with the AAMC, and we are grateful for the work of this group. With the assistance of the FOCI

Steering Committee leadership and the collaboration of partners across the AAMC membership and

broader research community, we will ensure that you are kept informed about new developments and

involved in these critical issues. Ross McKinney, Chief Scientific Officer, and I are always available to

you for questions or comments, so do not hesitate to reach out to us or to others in this group.

Heather H. Pierce, JD, MPH

Senior Director, Science Policy

Regulatory Counsel, Scientific Affairs

Association of American Medical Colleges

655 K Street NW, Suite 100

Washington, DC 20001

T: 202-478-9926  E: hpierce@aamc.org             www.aamc.org

For additional information see the attached document.

https://research.ouhsc.edu/Portals/1329/Assets/Documents/AAMC_Memo to FOCI on COI Issues Sept 2018.pdf?ver=2018-10-01-072212-030

 

VPR Staff Editor

Kathy Kyler is the staff editor for the OUHSC campus. Her assistance is available on request without

charge through the office of the Vice President for Research. You can contact her by e-mail at

Kathy-Kyler@ouhsc.edu or by calling ORA at 271-2090. Please allow sufficient time for review.

In general, turnaround time is 7 business days for manuscripts and 5 business days for grant

proposals of 12 pages or less for the research plan.

 

   

Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS

The abstract submission deadline for the HHDC 2018 Research Symposium is Friday, October 5th

Abstracts must be received by 5 p.m. HHDC 2018 Research Symposium will be held on Friday,

November 16, 2018 at the Samis Education Center in Children’s Hospital in Oklahoma City.

The Symposium will consist of selected oral presentations, a poster session, and Symposia talks by

Silvia Corvera, MD, Professor, University of Massachusetts Medical School, Timothy McGraw PhD,

Professor, Cornell Weill College of Medicine and Morris White, PhD, Professor, Harvard University. 

For abstract submission guidelines and to RSVP for this free event, please go to: 

http://www.haroldhamm.org/Research/Symposium.aspx  Please contact Katie-Hoefling@ouhsc.edu 

with any questions for this event.

 

 

Funding to complete the Master of Science degree in Clinical and Translational Sciences

Now seeking applications for the NIMHD-funded research training and career development program. 

The goal of the program is to facilitate the education of participants from diverse backgrounds under-

represented in biomedical research to pursue clinical research or population health research on diseases

that disproportionately impact minority and rural populations in Oklahoma. 

The program provides two years of partial salary and research support to complete the Master of Science

degree in Clinical and Translational Sciences (MS in CTS) that is administered through the OUHSC

Graduate College.  To be eligible, applicants must hold a clinical doctoral degree or PhD, be from a group

underrepresented in biomedical research (racial and ethnic groups that have been shown by the National

Science Foundation to be underrepresented in biomedical research or individuals with disabilities), be

within seven years of their first faculty appointment, AND plan to pursue a research career focused on

minority health or health disparities research.  The 2-year program covers 50% protected time (salary+fringe),

tuition and fees for the MS in CTS degree program, travel to professional meetings, and modest research funds.

Applications are due 10/15/18. 

Application materials can be found at:  http://osctr.ouhsc.edu/clinical-research-education-and-career-development

For additional information, please contact Julie Stoner, PhD (julie-stoner@ouhsc.edu).

 

 

END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer

Conference

Dates: December 6-7, 2018

Location: Samis Education Center

Registration and Call for Abstracts: http://end2cancer.com/

Summary: The END2CANCER conference will start the morning of December 6th, 2018 and conclude

in the afternoon of December 7th, 2018. The conference will bridge laboratory research conducted in

the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis,

imaging and treatment of cancer. The conference will host keynote, plenary and invited lectures by

eminent scientists who will discuss new and emerging concepts, technologies and challenges in

translating nanomedicine from bench-to-bedside.

Topics to be discussed in the planned thematic sessions include barriers in drug delivery, discovery

and applications, biological and non-biological systems as carriers and therapeutics, molecular imaging,

biomimetics, immune-oncology, toxicology and clinical trials.

The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers,

physicists, chemists, post-doctoral fellows, high-school and college students, patient advocates, business

professionals, educators and technology transfer specialists. Students and fellows will have an opportunity

to present their work as a poster presentation and compete for awards.

 

 

NIH NOTICES

 

Notice of Pre-Application Webinar for RFA-AG-19-010: "Alzheimer Centers for Discovery of New

Medicines (U54 Clinical Trial Not Allowed)" (NOT-AG-18-028)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-18-028.html

 

Notice of Correction to the Funding Opportunity Description for PAR-18-899 "Pre-Application: Research

Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not

Allowed)" (NOT-AR-19-018)
https://grants.nih.gov/grants/guide/notice-files/NOT-AR-19-018.html

 

Notice of Correction to the Funding Opportunity Description for PAR-18-900 "Pre-Application: Research

Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)"

(NOT-AR-19-019)
https://grants.nih.gov/grants/guide/notice-files/NOT-AR-19-019.html

 

Notice of Clarification to Additional Information on Eligibility and Number of Applications in Funding

Opportunity Announcement (FOA) PAR-18-880, "NCI Outstanding Investigator Award (R35 Clinical

Trial Not Allowed)" (NOT-CA-18-107)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-18-107.html

 

Notice of Change to Application Types Allowed for PAR-18-919 "Quantitative Imaging Tools and

Methods for Cancer Response Assessment (R01 Clinical Trial Optional)" (NOT-CA-18-109)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-18-109.html

 

Notice of a Pre-Application Webinar for RFA-CA-19-016 "Fusion Oncoproteins in Childhood Cancers

(FusOnC2) Consortium (U54)" (NOT-CA-18-110)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-18-110.html

 

Notice to Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-18-906 Research

Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not

Allowed) (NOT-DA-18-038)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-18-038.html

 

Request for Information: Optimizing the Design and Implementation of Emergency Medical Care

Research Conducted Under Exception from Informed Consent Requirements for Emergency Research

(EFIC) Requirements and Guidelines (NOT-HL-18-654)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-654.html

 

Notice of Clarification: Research Strategy page limit for PA-18-794, AHRQ Small Research Grant

Program (R03) (NOT-HS-18-016)
https://grants.nih.gov/grants/guide/notice-files/NOT-HS-18-016.html

 

Special Reminder: AHRQ Natural Disaster Policy - Hurricane Florence (NOT-HS-18-017)
https://grants.nih.gov/grants/guide/notice-files/NOT-HS-18-017.html

 

 

Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

 

The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) (RFA-CA-19-002)

Deadline February 22, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-002.html  

 

Responding to Opioid Use Disorders (OUD) in Tribal Communities in the Context of SAMHSA and

CDC Funding (R61/R33 - Clinical Trials Optional) (RFA-DA-19-013) – Deadline November 29, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-013.html  

 

Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder

Pharmacotherapies (R43/R44 - Clinical Trial Optional) (RFA-DA-19-014) – Deadline December 14, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-014.html  

 

Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder

Pharmacotherapies (R41/R42 - Clinical Trial Optional) (RFA-DA-19-015) – Deadline December 14, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-015.html

 

HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid

Crisis (Research Sites) (UM1 - Clinical Trial Required) (RFA-DA-19-016) – Deadline December 11, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-016.html  

 

HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid

Crisis (Data Coordinating Center) (UM1 - Clinical Trials Not Allowed) (RFA-DA-19-017)

Deadline December 11, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-017.html  

 

NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not

Allowed) (RFA-DE-19-005) – Deadline December 5, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DE-19-005.html  

 

Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChiLDReN)

Clinical Centers (U01 Clinical Trial Required) (RFA-DK-18-501) – Deadline November 20, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-501.html  

 

Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChiLDReN)

Scientific and Data Coordinating Center (U24 Clinical Trial Optional) (RFA-DK-18-502)

Deadline November 20, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-502.html  

 

Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Research Centers

(U01 Clinical Trial Not Allowed) (RFA-DK-18-507) – Deadline November 21, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-507.html  

 

Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Coordinating Center

(U24 Clinical Trial Not Allowed) (RFA-DK-18-508) – Deadline November 21, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-508.html  

 

Research Centers in Minority Institutions (RCMI) (U54)- Clinical Trials Optional (RFA-MD-18-012)

Deadline November 21, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-MD-18-012.html

 

BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell

Census (R01 Clinical Trial Not Allowed) (RFA-MH-19-148) – Deadline January 22, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-148.html  

 

BRAIN Initiative Cell Census Network (BICCN) Specialized Collaboratory on Human and Non-Human

Primate Brain Cell Atlases (U01 Clinical Trial Not Allowed) (RFA-MH-19-149) – Deadline January 22, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-149.html  

 

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia

(R01 Clinical Trial Optional) (RFA-MH-19-510) – Deadline November 19, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-510.html

 

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia

(R21 Clinical Trial Optional) (RFA-MH-19-511) – Deadline November 19, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-511.html  

 

Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial

Not Allowed) (RFA-NS-18-042) – Deadline November 27, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-042.html  

 

Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial

Not Allowed) (RFA-NS-18-043) – Deadline November 27, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-043.html  

 

Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)

(RFA-NS-18-046) – Deadline November 27, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-046.html

 

Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp)

(PA-18-926) – Deadline: Applications are accepted on a rolling basis and reviewed approximately four

times a year (November, February, April, and May). Submit by the first of the preceding month to have

your application reviewed at one of the listed months.
https://grants.nih.gov/grants/guide/pa-files/PA-18-926.html  

 

Innovative Technologies for HIV Behavioral and Social Science Research (R41/R42 Clinical Trial Optional)

(PA-18-927) – Deadline January 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-18-927.html  

 

Innovative Technologies for HIV Behavioral and Social Science Research (R43/R44 Clinical Trial Optional)

(PA-18-928) – Deadline January 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-18-928.html  

 

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

(PA-18-932) – Deadline February 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-18-932.html

 

Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals

(R21 Clinical Trial Not Allowed) (PAR-18-923) – Deadline January 14, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-18-923.html

 

Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity

Prevention and Care (R34 Clinical Trial Required)  (PAR-18-924) – Deadline November 1, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-924.html  

 

Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care

(R18 Clinical Trial Required) (PAR-18-925) – Deadline November 1, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-925.html  

 

High-Priority Areas for Research Leveraging EHR and Large-Scale Data (R01 Clinical Trial Not

Allowed) (PAR-18-929) – Deadline November 21, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-929.html

 

Development and Optimization of Tasks and Measures for Functional Domains of Behavior

(R01 Clinical Trial Not Allowed) (PAR-18-930) – Deadline February 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-18-930.html  

 

Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community

Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl –

Clinical Trial Not Allowed) (PAR-18-931) – Deadline December 15, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-931.html

 

Print

Name:
Email:
Subject:
Message:
x